Professor Jean-François Korobelnik from the University Hospital of Bordeaux, France reviews the results at one year of the PHOTON and PULSAR studies testing the safety and efficacy of Aflibercept 8mg injections for Wet AMD and DME. The results at two years will be presented at the end of 2023.
PHOTON and PULSAR studies: an overview of the results
Aflibercept 8 mg accepted by FDA for priority review for the treatment of wet AMD and DME
FDA has accepted for priority
LEARN MORE
Real-world evidence confirms the good outcomes of aflibercept in DME
Jean-François Korobelnik speaks about real-world outco
LEARN MORE
Efficacy of anti-VEGF therapy for wet AMD in real life
From a large meta-analysis of RCT and observational stu
LEARN MORE